# of Displayed Technologies: 4 / 4


Categories

Independent speed variable frequency generator for more electric aircraft using brushless doubly-fed machines (BDFM)
TS-050232 — Independent speed variable frequency generator for more electric aircraft using brushless doubly-fed machines (BDFM)
Technology continues to advance and with it, a push for higher performance of electrical components and devices, especially in the transportation industry. For example, in the past few decades, considerable efforts have been taken towards aircraft electrification. Traditional hydraulic and pneumat…
  • College: College of Engineering (COE)
  • Inventors: Zhang, Julia; Peng, Peng; Xu, Longya
  • Licensing Officer: Hong, Dongsung

A Bi-layered Capsule for Sustainable Delivery of Protein Therapeutics
TS-042858 — A biodegradable drug delivery system for the treatment of disease, especially ophthalmic diseases including age-related macular degeneration (AMD). The device will be injected and can control drug release for at least 6 months following the initial injection.
Retinal diseases can be extremely difficult to monitor once procedures have been initiated. AMD is the fourth most common causes of blindness and requires monthly injections to manage the effects of the disease and prevent permanent blindness. However, receiving recurrent injections can potentiall…
  • College: College of Engineering (COE)
  • Inventors: Jiang, Pengfei; Lannutti, John; Ohr, Matthew; Swindle-Reilly, Katelyn
  • Licensing Officer: Norris, Francis "Frank"

Sustained Release Microparticles for the Treatment of Ocular Diseases
TS-038312 — A novel, intravitreal microparticle injection capable of controlled-release of protein therapies (including anti-VEGF) for tunable periods of 6-12 months after injection for the treatment of age-related macular degeneration.
Age-related macular degeneration (AMD) is the leading cause of blindness in individuals 65 and older and is the third leading cause of blindness worldwide. Wet AMD is characterized by abnormal growth of leaky blood vessels leading to damage to the macula of the retina resulting in vision loss and …
  • College: College of Engineering (COE)
  • Inventors: Jiang, Pengfei; Ohr, Matthew; Swindle-Reilly, Katelyn
  • Licensing Officer: Norris, Francis "Frank"

New anthracycline analogues to overcome multidrug resistance
TS-015117 — Analogues therapy to overcome multi-drug resistance in cancer cells
The Need Daunorubicin is the standard anthracycline agent, a class of anti-tumor compounds used widely in the treatment of a variety of cancers. As multiple drug resistance and toxicity are serious clinical problems associated with daunorubicin, researchers have focused on improving this common …
  • College: College of Pharmacy
  • Inventors: Sun, Duxin; Fang, Lanyan; Wang, Peng George; Zhang, Guisheng
  • Licensing Officer: He, Panqing

Loading icon